Evidence map›Paper›PMID 40122793›Full record

ArticleBMC cancer2025

The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study.

Jetske A Kraan, Michiel A Greidanus, Sietske J Tamminga, Jan L Hoving

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jetske A KraanDepartment of Social Medical Affairs (SMZ), The Dutch Social Security Institute, The Institute for Employee Benefits Schemes (UWV), La Guardiaweg 94-114, Amsterdam, 1043 DL, The Netherlands. jetske.kraan@uwv.nl.
Michiel A GreidanusDepartment of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Sietske J TammingaDepartment of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
Jan L HovingDepartment of Public and Occupational Health, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere is a lack of consensus among physicians working in the field of disability assessment about the definition of a limited life expectancy. The aim of this study was to describe the mortality rate of employees with cancer who were judged to have a limited life expectancy and to study whether factors are associated with mortality.

methodsA retrospective cohort study, including 534 Dutch employees with a diagnosis of cancer who were granted full work disability pension after being judged by physicians working in the field of disability assessment as having a limited life expectancy. Descriptive statistics were used to describe the one- and two-year mortality rates. Factors potentially associated with mortality were studied using univariate logistic regression analysis.

resultsThe mortality rates one and two years after the disability assessment were 46% (n = 247) and 63% (n = 339), respectively. We did not observe a statistically significant association between age at death or between sex and death after one year, but after two years the probability of death was greater among men. Both one and two-years after the disability assessment, the probability of dying was greater among employees diagnosed with a digestive type of cancer, compared to employees diagnosed with a urogenital type of cancer.

conclusionsApproximately six in ten people died within two years of their work disability assessment. In addition to the type of cancer, no factors in this study were associated with mortality. Physicians should be supported in making evidence-based assessments of life expectancy in patients with cancer.

Indexed as

Disability EvaluationLife ExpectancyNeoplasmsAdultAgedFemaleHumansMaleMiddle AgedNetherlandsPersons with DisabilitiesPhysiciansRetrospective StudiesCohort studiesLimited life expectancyMortalityPrognosisSocial security

Identifiers

PMID40122793
PMCPMC11930007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.